BioTelemetry, Inc. BEAT shares dipped after the company missed fourth-quarter earnings expectations on a narrowing profit margin.
The medical technology company changed hands recently at $10.02, down 6.8 percent.
BioTelemetry said profits were hurt by a lower margin patient mix and higher expense, both resulting from its acquisition of Mednet and BMS.
The company acquired Mednet Healthcare Technologies Inc. a year ago for $16 million and Biomedical Systems Corp. for $8.65 million in March of last year.
BioTelemetry posted a fourth-quarter net loss of $1.7 million, or $0.06 a share, compared with breakeven results a year earlier.
Adjusted profit equaled $0.05 a share, while revenue grew nearly 32 percent to $43.7 million, from $33.1 million a year earlier.
Wall Street expected adjusted earnings of $0.06 a share, on revenue of $43.36 million.
The company didn't immediately offer earnings guidance.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
